Sahar Safaei

1000 total citations
31 papers, 722 citations indexed

About

Sahar Safaei is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sahar Safaei has authored 31 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Sahar Safaei's work include MicroRNA in disease regulation (11 papers), Immunotherapy and Immune Responses (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Sahar Safaei is often cited by papers focused on MicroRNA in disease regulation (11 papers), Immunotherapy and Immune Responses (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Sahar Safaei collaborates with scholars based in Iran, Italy and Denmark. Sahar Safaei's co-authors include Behzad Baradaran, Afshin Derakhshani, Nicola Silvestris, Oronzo Brunetti, Zahra Asadzadeh, Ahad Mokhtarzadeh, Roya Shahbazi, Antonella Argentiero, Monireh Khordadmehr and Ali Mohammadi and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Sahar Safaei

29 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sahar Safaei Iran 15 349 287 186 185 103 31 722
Xuli Meng China 14 489 1.4× 257 0.9× 128 0.7× 220 1.2× 114 1.1× 43 792
Guangshun Sun China 16 478 1.4× 230 0.8× 168 0.9× 271 1.5× 120 1.2× 27 790
Huizhen Suo Germany 5 398 1.1× 328 1.1× 101 0.5× 239 1.3× 79 0.8× 7 730
He Dou China 5 302 0.9× 218 0.8× 126 0.7× 207 1.1× 99 1.0× 10 646
Carly Bess Scalise United States 13 295 0.8× 269 0.9× 255 1.4× 134 0.7× 69 0.7× 33 673
Lia Walcher Germany 5 395 1.1× 317 1.1× 94 0.5× 234 1.3× 79 0.8× 5 717
Diego Serrano Spain 15 410 1.2× 278 1.0× 138 0.7× 159 0.9× 136 1.3× 25 750
Sandy Azzi France 13 330 0.9× 200 0.7× 149 0.8× 137 0.7× 68 0.7× 18 693
Wubin Zheng China 9 325 0.9× 193 0.7× 165 0.9× 262 1.4× 134 1.3× 12 618
Benoît Thibault France 12 409 1.2× 312 1.1× 160 0.9× 185 1.0× 84 0.8× 21 797

Countries citing papers authored by Sahar Safaei

Since Specialization
Citations

This map shows the geographic impact of Sahar Safaei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sahar Safaei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sahar Safaei more than expected).

Fields of papers citing papers by Sahar Safaei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sahar Safaei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sahar Safaei. The network helps show where Sahar Safaei may publish in the future.

Co-authorship network of co-authors of Sahar Safaei

This figure shows the co-authorship network connecting the top 25 collaborators of Sahar Safaei. A scholar is included among the top collaborators of Sahar Safaei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sahar Safaei. Sahar Safaei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Safaei, Sahar, et al.. (2025). The role of cytokines in shaping the future of Cancer immunotherapy. Cytokine. 189. 156888–156888. 3 indexed citations
2.
Safaei, Sahar, et al.. (2025). Dendritic cell-derived extracellular vesicles as a promising immunotherapeutic strategy for cancer: A Systematic Review. SHILAP Revista de lepidopterología. 13. 35029–35029.
3.
Ghorbani, Marjan, et al.. (2025). Exploring the potential of gemcitabine-metal–organic frameworks in combating pancreatic cancer under ketogenic conditions. BMC Cancer. 25(1). 53–53. 1 indexed citations
4.
Khalaj‐Kondori, Mohammad, et al.. (2024). Co-targeting NRF2 potentially enhances the in vitro anticancer effects of paclitaxel in gastric cancer cells. Discover Oncology. 15(1). 424–424.
5.
Shekari, Najibeh, Dariush Shanehbandi, Elham Baghbani, et al.. (2024). VSIG-3/IGSF11 silencing in A2058 melanoma cells simultaneously suppresses melanoma progression and induces anti-tumoral cytokine profile in human T cells: In silico and in vitro study. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(4). 3861–3880. 1 indexed citations
6.
7.
8.
Masoumi, Javad, Farid Ghorbaninezhad, Hossein Saeedi, et al.. (2023). siRNA-Mediated B7H7 Knockdown in Gastric Cancer Lysate-Loaded Dendritic Cells Amplifies Expansion and Cytokine Secretion of Autologous T Cells. Biomedicines. 11(12). 3212–3212. 7 indexed citations
9.
Najafi, Souzan, Rouhollah Motafakkerazad, Mohammad Amini, et al.. (2023). Targeting Nanog expression increased Cisplatin chemosensitivity and inhibited cell migration in Gastric cancer cells. Experimental Cell Research. 429(2). 113681–113681. 3 indexed citations
10.
Safaei, Sahar, Mohammad Amini, Ahad Mokhtarzadeh, et al.. (2022). miR-200c increases the sensitivity of breast cancer cells to Doxorubicin through downregulating MDR1 gene. Experimental and Molecular Pathology. 125. 104753–104753. 25 indexed citations
11.
Safaei, Sahar, et al.. (2022). Evaluation of lncRNA FOXD2-AS1 Expression as a Diagnostic Biomarker in Colorectal Cancer. PubMed. 11(3). 471–478. 4 indexed citations
12.
Shadbad, Mahdi Abdoli, Sahar Safaei, Oronzo Brunetti, et al.. (2021). A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery. Genes. 12(8). 1206–1206. 52 indexed citations
13.
Taefehshokr, Sina, Nima Taefehshokr, Afshin Derakhshani, et al.. (2021). The Regulatory Role of Pivotal MicroRNAs in the AKT Signaling Pathway in Breast Cancer. Current Molecular Medicine. 22(3). 263–273. 9 indexed citations
14.
Khaze, Vahid, Mohammad Amini, Sahar Safaei, et al.. (2021). Suppression of Nanog inhibited cell migration and increased the sensitivity of colorectal cancer cells to 5-fluorouracil. European Journal of Pharmacology. 894. 173871–173871. 17 indexed citations
15.
Safaei, Sahar, et al.. (2021). Evaluation of miR-107, DAPK1, and KLF4 Expression in Colorectal Tumors and Effect of Oxaliplatin and 5-FU on their Levels in Colorectal Cancer Cell Lines. SHILAP Revista de lepidopterología. 12(2). 190–197. 1 indexed citations
16.
Lotfinejad, Parisa, Tohid Kazemi, Sahar Safaei, et al.. (2021). PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines. Biomedicine & Pharmacotherapy. 138. 111436–111436. 39 indexed citations
17.
Shahbazi, Roya, et al.. (2020). Targeting ROCK signaling in health, malignant and non-malignant diseases. Immunology Letters. 219. 15–26. 73 indexed citations
18.
Asadzadeh, Zahra, Elham Safarzadeh, Sahar Safaei, et al.. (2020). Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death. Cancers. 12(4). 1047–1047. 127 indexed citations
19.
Kooshkaki, Omid, Afshin Derakhshani, Negar Hosseinkhani, et al.. (2020). Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials. International Journal of Molecular Sciences. 21(12). 4427–4427. 95 indexed citations
20.
Mokhtarzadeh, Ahad, Leili Aghebati‐Maleki, Behzad Mansoori, et al.. (2020). CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel. Molecular Biology Reports. 47(5). 3691–3703. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuli Meng Breakdown of academic impact, for papers by Guangshun Sun Breakdown of academic impact, for papers by Huizhen Suo Breakdown of academic impact, for papers by He Dou Breakdown of academic impact, for papers by Carly Bess Scalise Breakdown of academic impact, for papers by Lia Walcher Breakdown of academic impact, for papers by Diego Serrano Breakdown of academic impact, for papers by Sandy Azzi Breakdown of academic impact, for papers by Wubin Zheng Breakdown of academic impact, for papers by Benoît Thibault
Rankless by CCL
2026